Core Laboratories N.V. (CLB) Stock Overview
Explore Core Laboratories N.V.’s financial performance, market position, analyst ratings, and future outlook.
Core Laboratories N.V. (CLB)
Key Financials
Key Financials
Market Cap
538.9M
P/E Ratio
17.97
EPS (TTM)
$0.68
ROE
0.11%
CLB Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Core Laboratories N.V. (NYSE: CLB) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Core Laboratories N.V.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CLB on the NYSE shows an RSI of 47.58, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $10.90 for the NYSE listing.
Key metrics behind Core Laboratories N.V.'s NYSE-traded stock include a P/E ratio of 17.97 and a market capitalization of 538.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CLB on the NYSE.